수면 보조 보충제 시장 예측(-2030년) : 제품별, 형태별, 유통 채널별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Sleep Aid Supplements Market is accounted for $96.2 billion in 2023 and is expected to reach $193.5 billion by 2030 growing at a CAGR of 10.5% during the forecast period. Sleep aid supplements are substances, typically in the form of pills, capsules, or liquids, that are consumed to help improve sleep quality and promote relaxation. These supplements often contain natural ingredients such as herbs, vitamins, minerals, and amino acids that are believed to have calming or sedative effects on the body, helping to alleviate insomnia, reduce anxiety, and induce sleepiness.

According to the U.S. Sleep Association from which, around 30-50% of the people show signs of Insomnia whereas 10-20% have long-lasting insomnia.

Market Dynamics:

Driver:

Growing prevalence of sleep disorders

The market has witnessed a surge in demand due to the growing prevalence of sleep disorders. Factors such as high stress levels, irregular lifestyles, and increased screen time have contributed to rising instances of insomnia and other sleep-related issues. Consequently, consumers are turning to sleep aid supplements as a solution to improve sleep quality and duration. This trend is expected to continue driving growth in the market as more individuals seek effective remedies for their sleep disturbances.

Restraint:

Limited efficacy of some products

While many supplements claim to improve sleep quality, their effectiveness may vary widely among individuals, leading to dissatisfaction among consumers. Additionally, there's a lack of regulation and standardized testing for these products, making it difficult for consumers to discern which ones will truly deliver results. This presents a barrier to market growth and calls for more rigorous research and transparency within the industry.

Opportunity:

Easy availability of products

Sleep aid supplements are increasingly accessible, with a plethora of options readily available in the market. From traditional herbal remedies like valerian root and chamomile to modern formulations incorporating melatonin and magnesium, consumers have a wide array of choices to address their sleep concerns. Additionally, the rise of online retail platforms and health stores ensures easy access to these products, further contributing to their widespread availability and convenience for consumers seeking better sleep solutions.

Threat:

Potential side effects

While these products promise improved sleep quality and duration, adverse reactions such as daytime drowsiness, dizziness, and gastrointestinal discomfort may occur. Some individuals might also experience dependency or tolerance issues with long-term use. Moreover, the interaction of sleep aids with other medications or underlying health conditions underscores the importance of consulting healthcare professionals before usage. Hence, this is the major factor hampering the growth of the market.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the Sleep Aid Supplements Market. With heightened stress, anxiety, and disrupted routines, many individuals experienced sleep disturbances during lockdowns and periods of uncertainty. This led to an increased demand for sleep aid supplements as people sought solutions for improving sleep quality and managing insomnia. Moreover, the growing awareness of the importance of sleep for overall health and well-being further fueled the market's growth, resulting in a notable surge in sales and consumption of sleep aid supplements.

The melatonin segment is expected to be the largest during the forecast period

The melatonin segment is expected to be the largest during the forecast period. Melatonin's popularity stems from its perceived effectiveness in promoting better sleep quality and managing sleep disorders. With increasing consumer interest in natural remedies for sleep issues, manufacturers are formulating supplements with varying melatonin concentrations to cater to different preferences and needs. This trend reflects a growing preference for holistic approaches to addressing sleep disturbances within the wellness industry.

The chronic insomnia segment is expected to have the highest CAGR during the forecast period

The chronic insomnia segment is expected to have the highest CAGR during the forecast period. With an increasing number of individuals seeking relief from sleep disturbances, the demand for effective remedies has surged. Sleep aid supplements, offering natural and non-habit forming solutions, have gained traction among consumers. This trend has prompted manufacturers to innovate and introduce a diverse range of products tailored to address various sleep-related issues, thereby expanding the market for sleep aid supplements.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by increasing consumer awareness of the importance of sleep for overall health and well-being. Factors such as high-stress levels and lifestyle changes contribute to the demand for natural and herbal sleep aids. Additionally, technological advancements and innovations in formulations are enhancing product efficacy and safety.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to rapid urbanization and hectic lifestyles. The proliferation of e-commerce platforms has significantly contributed to the accessibility of sleep aid supplements in the region. Consumers in the region are increasingly inclined towards natural and herbal sleep aid supplements due to their perceived safety and efficacy.

Key players in the market

Some of the key players in Sleep Aid Supplements market include Pfizer, Novel Laboratories, Inc., Sanofi Aventis, Takeda Pharmaceutical, Philips, Nested Naturals, Sumitomo Dainippon Pharma, NutraScience Labs, Merck & Co. , Sanofi, Sundown Naturals, Nature Made, Nestle Health Science, King Pharmaceuticals, DSM , Johnson & Johnson and ResMed.

Key Developments:

In October 2022, Pfizer Inc. has officially concluded its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the renowned manufacturer of NURTEC ODT (rimegepant).

In August 2022, ResMed has disclosed its successful acquisition of Mementor, a Leipzig-based company. This strategic move bolsters ResMed's comprehensive sleep product offerings in Germany, introducing a digital solution tailored to address insomnia concerns.

Products Covered:

• Herbal Supplements
• Antihistamines
• Melatonin
• Glycine
• Other Products

Forms Covered:

• Powder
• Capsules
• Liquid
• Tablets
• Gummies
• Other Forms

Distribution Channels Covered:

• Specialty Stores
• Online Retailers
• Supermarkets
• Hypermarkets

Applications Covered:

• Occasional Sleeplessness
• Chronic Insomnia
• Jet Lag
• Sleep Apnea
• Other Applications

End Users Covered:

• Food and Beverage
• Pharmaceutical
• Nutraceutical
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Sleep Aid Supplements Market, By Product

• 5.1 Introduction
• 5.2 Herbal Supplements
• 5.3 Antihistamines
• 5.4 Melatonin
• 5.5 Glycine
• 5.6 Other Products

6 Global Sleep Aid Supplements Market, By Form

• 6.1 Introduction
• 6.2 Powder
• 6.3 Capsules
• 6.4 Liquid
• 6.5 Tablets
• 6.6 Gummies
• 6.7 Other Forms

7 Global Sleep Aid Supplements Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Specialty Stores
• 7.3 Online Retailers
• 7.4 Supermarkets
• 7.5 Hypermarkets

8 Global Sleep Aid Supplements Market, By Application

• 8.1 Introduction
• 8.2 Occasional Sleeplessness
• 8.3 Chronic Insomnia
• 8.4 Jet Lag
• 8.5 Sleep Apnea
• 8.6 Other Applications

9 Global Sleep Aid Supplements Market, By End User

• 9.1 Introduction
• 9.2 Food and Beverage
• 9.3 Pharmaceutical
• 9.4 Nutraceutical
• 9.5 Other End Users

10 Global Sleep Aid Supplements Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Pfizer
• 12.2 Novel Laboratories, Inc.
• 12.3 Sanofi Aventis
• 12.4 Takeda Pharmaceutical
• 12.5 Philips
• 12.6 Nested Naturals
• 12.7 Sumitomo Dainippon Pharma
• 12.8 NutraScience Labs
• 12.9 Merck & Co.
• 12.10 Sanofi
• 12.11 Sundown Naturals
• 12.12 Nature Made
• 12.12 Nestle Health Science
• 12.14 King Pharmaceuticals
• 12.15 DSM
• 12.16 Johnson & Johnson
• 12.17 ResMed